Education
About Us
Working with TipRanks
Follow Us
Kevin Oboyle Insider Profile
4 Followers
Kevin Oboyle, Director at GenMark, holds 17.33K shares in Carlsmed, Inc. (Ticker: CARL), holds 2.04K shares in Irhythm Technologies (Ticker: IRTC), holds 24.12K shares in Outset Medical (Ticker: OM).
Profitable Transactions
3 out of 7 Profitable Transactions
Average Return
+41.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kevin Oboyle holds in companies
Most Profitable Insider Trade
Stock:
GenMark
(GNMK)
(GNMK)
Rating:Informative Buy
Date:Mar 09, 2020 - Mar 09, 2021
Return:+305.70%
The most profitable trade made by Kevin Oboyle
Kevin Oboyle's Trading History
GenMark
Apr 22, 2021
―
Uninformative Sell
3.17M
$0.00
Wright Medical Group
Jul 30, 2019
―
Uninformative Buy
―
$488.85K
Nevro Corp
Apr 03, 2025
―
Uninformative Sell
―
$0.00
Outset Medical
Jun 04, 2025
Director
Uninformative Buy
―
$118.18K
Irhythm Technologies
Jul 08, 2025
Director
Uninformative Buy
―
$310.26K
Carlsmed, Inc.
Jul 24, 2025
Director
Uninformative Buy
―
$199.50K
Wright Medical Group, Inc.
―
―
―
―
Zeltiq Aesthetics
Apr 28, 2017
―
Uninformative Sell
―
$326.79K
Sientra
Jun 13, 2022
―
Uninformative Buy
―
$5.52K
NuVasive
Dec 17, 2009
―
Uninformative Sell
1.29M
$132.69K
Durata
Nov 17, 2014
―
Uninformative Sell
―
―
List of latest transactions for each holding click on a transaction to see Kevin Oboyle's performance on stock
You May Also Like
Kevin Oboyle insider profile FAQ
What is the percentage of profitable transactions made by Kevin Oboyle?
The percentage of profitable transactions made by Kevin Oboyle is 43%.
What is the average return per transaction made by Kevin Oboyle?
The average return per transaction made by Kevin Oboyle is 41.80%.
What stocks does Kevin Oboyle hold?
Kevin Oboyle holds: GNMK, WMGI, NVRO, OM, IRTC, CARL, ~WMGI, ZLTQ, SIENQ, NUVA, DRTX stocks.
What was Kevin Oboyle’s latest transaction?
Kevin Oboyle latest transaction was an Uninformative Buy of ―.
What was Kevin Oboyle's most profitable transaction?
Kevin Oboyle’s most profitable transaction was an Informative Buy of GNMK stock on March 9, 2020. The return on the trade was 305.70%.
What is Kevin Oboyle's role in GenMark?
Kevin Oboyle's role in GenMark is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.